Given the crucial role of CD8α+ cDC1s in suppressing GvHD while promoting GvL responses, the role of pre-cDC1s in induction of alloreactive T-cell responses and anti-tumor responses is of great clinical significance for HCT. The gene discussed is CD8A; the disease is neoplasm.